Manufacturers Want Delay In Conducting US Nitrosamine Risk Assessments

Pandemic And Volume Of Work Precluding Timely Assessments

 
• By Joanne S. Eglovitch
  
3D illustration of Facsimile Metformin bottle on shelf
Manufacturers Complain Of Tight Deadline For Conducting Nitrosamine Risk Assessments • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Manufacturing

More from Compliance